Speeple News Search

Search: |

Tags | Domains | Searches | Statistics | Options | Advanced Search

xconomy.com » Feeds » Xconomy Seattle

Yearly Archives: 2008

Latest news from Xconomy Seattle

  1. Washington and Oregon Could Lead the U.S. in Cleantech Under New Policies, Report Says

    Washington and Oregon Could Lead the U.S. in Cleantech Under New Policies, Report Says

    22 hours ago

    renewable energy, cleantech, innovation Gregory T. Huang wrote: The Pacific Northwest could potentially be the first region in the United States to achieve 75 percent of its electricity supply from carbon-free sources

    Tagged: energy, innovation, policy, manufacturing, seattle, vc, venture capital, reports, employment, solar, sensors, communications, wind power, carbon, renewable energy, biofuels, photovoltaics, northwest, wind farms, green buildings, green tech, tax credits, clean edge, itron, smart grid, cleantech, climate solutions, bioenergy, pacific ethanol, sequential biofuels, imperium, national blog main, seattle blog main, solarworld, z jobs, advanced meters

  2. Cooley Godward Snaps Up Heller Ehrman Refugees in Seattle

    22 hours ago

    Biotech, Legal, Cooley Godward Luke Timmerman wrote: Cooley Godward Kronish, a national law firm, is opening an office in Seattle five years after it left the region in the wake of the dot-com bust. The new Cooley

    Tagged: legal, seattle, biotech, life sciences, heller ehrman, seattle briefs, cooley godward

  3. ISB, Complete Genomics Form Partnership To Sequence Multiple Human Genomes

    22 hours ago

    Biotech, Genomics, Institute for Systems Biology Luke Timmerman wrote: The Institute for Systems Biology and Complete Genomics, a Mountain View, CA-based maker of DNA sequencing technology, have formed a partnership

    Tagged: seattle, biotech, genomics, life sciences, seattle briefs, institute for systems biology, complete genomics

  4. Dendreon Stock Booms As Provenge Shows Promise in Pivotal Trial

    Dendreon Stock Booms As Provenge Shows Promise in Pivotal Trial

    22 hours ago

    Biotech, cancer, Dendreon Luke Timmerman wrote: Dendreon’s stock rocketed up 33 percent today on good news for its Provenge treatment for prostate cancer. The Seattle biotech company (NASDAQ: DNDN) said today that an

    Tagged: cancer, seattle, biotech, fda, prostate cancer, life sciences, provenge, dendreon, mitchell gold, national blog main, seattle blog main

  5. OVP, Enterprise Partners See Big Opportunity in $5,000 Human Genome Sequencing

    OVP, Enterprise Partners See Big Opportunity in $5,000 Human Genome Sequencing

    Oct 6, 2008

    Biotech, Sequencing, Complete Genomics Luke Timmerman wrote: It’s getting cheaper by the day to sequence the entire string of 6 billion chemical units of DNA that make up an individual human being. Yesterday, Complete

    Tagged: science, biotech, applied biosystems, san diego, nature, genentech, harvard medical school, national institutes of health, sequencing, life sciences, 454 life sciences, illumina, enterprise partners, ovp venture partners, seattle blog main, leroy hood, george church, helicos biosciences, chad waite, institute for systems biology, san diego blog main, highland capital management, complete genomics, bruce bigelow, prospect venture partners, clifford reid, drew senyei